United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $42.16 Million Holdings in Intuitive Surgical, Inc. $ISRG

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 94,268 shares of the medical equipment provider’s stock after buying an additional 14,517 shares during the period. Intuitive Surgical makes up 1.5% of United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s investment portfolio, making the stock its 25th largest holding. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in Intuitive Surgical were worth $42,159,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of ISRG. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after acquiring an additional 263,828 shares in the last quarter. State Street Corp grew its holdings in Intuitive Surgical by 1.2% in the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after purchasing an additional 182,871 shares during the period. Geode Capital Management LLC increased its stake in Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after purchasing an additional 109,904 shares in the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical during the second quarter valued at about $2,569,260,000. Finally, Invesco Ltd. raised its holdings in shares of Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after purchasing an additional 201,159 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on ISRG shares. Argus reduced their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. The Goldman Sachs Group reiterated a “buy” rating and issued a $714.00 price target on shares of Intuitive Surgical in a report on Friday, January 9th. BTIG Research restated a “buy” rating and set a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. Finally, TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $615.86.

Intuitive Surgical Price Performance

ISRG opened at $490.16 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The firm has a market capitalization of $174.07 billion, a PE ratio of 62.12, a P/E/G ratio of 3.78 and a beta of 1.66. The company’s 50-day moving average is $521.64 and its 200 day moving average is $512.28.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.21 EPS. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the completion of the sale, the director directly owned 3,694 shares of the company’s stock, valued at $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 37,261 shares of company stock worth $19,690,721 over the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.